+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanomedicine Global Market Report 2021: COVID-19 Growth and Change

  • PDF Icon

    Report

  • 175 Pages
  • October 2021
  • Region: Global
  • The Business Research Company
  • ID: 5458705
Nanomedicine Global Market Report 2021: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global nanomedicine market.





This report focuses on nanomedicine market which is experiencing strong growth. The report gives a guide to the nanomedicine market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for nanomedicine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Nanomedicine market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider nanomedicine market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The nanomedicine market section of the report gives context. It compares the nanomedicine market with other segments of the nanomedicine market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, nanomedicine indicators comparison.

Scope


Markets Covered:


  • By Type: Nanoparticles; Nanoshells; Nanotubes; Nanodevices; Others
  • By Modality: Diagnostics; Treatments
  • By Application: Clinical Oncology; Infectious Diseases; Clinical Cardiology; Orthopedics; Others

Companies Mentioned:


Pfizer Inc.; Nanotherapeutics Inc.; NanoViricides Inc; Arrowhead Research Inc.; Celgene Corporation

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data:


Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Nanomedicine Market

What is the estimated value of the Global Nanomedicine Market?

The Global Nanomedicine Market was estimated to be valued at $221.12 billion in 2021.

What is the growth rate of the Global Nanomedicine Market?

The growth rate of the Global Nanomedicine Market is 13.1%, with an estimated value of $361.44 billion by 2025.

What is the forecasted size of the Global Nanomedicine Market?

The Global Nanomedicine Market is estimated to be worth $361.44 billion by 2025.

Who are the key companies in the Global Nanomedicine Market?

Key companies in the Global Nanomedicine Market include Pfizer Inc., Nanotherapeutics Inc., NanoViricides Inc, Arrowhead Research Inc., Celgene Corporation, Bio, Gate AG, Merck AG and F. Hoffmann.

Table of Contents

1. Executive Summary2. Nanomedicine Market Characteristics3. Nanomedicine Market Trends and Strategies4. Impact Of COVID-19 On Nanomedicine
5. Nanomedicine Market Size and Growth
5.1. Global Nanomedicine Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Nanomedicine Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Nanomedicine Market Segmentation
6.1. Global Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices
  • Others
6.2. Global Nanomedicine Market, Segmentation by Modality, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Diagnostics
  • Treatments
6.3. Global Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopedics
  • Others

7. Nanomedicine Market Regional and Country Analysis
7.1. Global Nanomedicine Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Nanomedicine Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Nanomedicine Market
8.1. Asia-Pacific Nanomedicine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Nanomedicine Market
9.1. China Nanomedicine Market Overview
9.2. China Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Nanomedicine Market
10.1. India Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Nanomedicine Market
11.1. Japan Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Nanomedicine Market
12.1. Australia Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Nanomedicine Market
13.1. Indonesia Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Nanomedicine Market
14.1. South Korea Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Nanomedicine Market
15.1. Western Europe Nanomedicine Market Overview
15.2. Western Europe Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Nanomedicine Market
16.1. UK Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Nanomedicine Market
17.1. Germany Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Nanomedicine Market
18.4. France Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Nanomedicine Market
19.1. Eastern Europe Nanomedicine Market Overview
19.2. Eastern Europe Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Nanomedicine Market
20.1. Russia Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Nanomedicine Market
21.1. North America Nanomedicine Market Overview
21.2. North America Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Nanomedicine Market
22.1. USA Nanomedicine Market Overview
22.2. USA Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Nanomedicine Market
23.1. South America Nanomedicine Market Overview
23.2. South America Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Nanomedicine Market
24.1. Brazil Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Nanomedicine Market
25.1. Middle East Nanomedicine Market Overview
25.2. Middle East Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Nanomedicine Market
26.1. Africa Nanomedicine Market Overview
26.2. Africa Nanomedicine Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Nanomedicine Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Nanomedicine Market Competitive Landscape and Company Profiles
27.1. Nanomedicine Market Competitive Landscape
27.2. Nanomedicine Market Company Profiles
27.2.1. Pfizer Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Nanotherapeutics Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. NanoViricides Inc
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Arrowhead Research Inc.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Celgene Corporation
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Nanomedicine Market29. Nanomedicine Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer

Executive Summary

Major players in the nanomedicine market are Pfizer Inc., Nanotherapeutics Inc., NanoViricides Inc, Arrowhead Research Inc., Celgene Corporation, Bio-Gate AG, Merck AG, Ablynx NV, F. Hoffmann-La Roche AG, Nanospectra Biosciences, GE Healthcare, Gilead Sciences Inc., Novartis AG, Amgen Inc., and Sanofi.

The global nanomedicine market is expected to grow from $190.83 billion in 2020 to $221.12 billion in 2021 at a compound annual growth rate (CAGR) of 15.9%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $361.44 billion in 2025 at a CAGR of 13.1%.

The nanomedicine market consists of sales of nanotechnology-based applications in medicines by entities (organizations, sole-trader, and partnerships) that are engaged in utilizing nanomaterials for the enhanced diagnosis and treatment of various health issues. Nanomedicine is a branch of medicine that applies nanotechnology knowledge and tools for the prevention and treatment of disease. They are nanoscale materials that are used in diagnosis and treatment procedures in oncology, cardiology, infectious diseases, orthopedics, and other medical areas. Nanomedicine is an important instrument that enables personalized, targeted, and regenerative medicine by delivering improved new drugs, treatments, and implantable devices to clinicians and patients.

The main types of nanomedicine are nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles are a type of ultrafine particles usually between 1 and 100 nanometers in diameter used in making medicine and drugs. The different forms of modality include diagnostics, treatments and are used in clinical oncology, infectious diseases, clinical cardiology, orthopedics, others.

North America was the largest region in the nanomedicine market in 2020. The Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The 4D Nanomedicine is a key trend gaining popularity in the nanomedicine market. 4D nanomedicine is used in medical procedures for safer treatment with nanoparticles. 4D nanomedicine is made with biodegradable and biocompatible nanoalloys that do not accumulate in the body, thus, limiting the side effects. The 4D nanomedicine is accepted as a fundamental development in the treatment and diagnosis of cancer. For instance, in 2020, a research team from The Department of Chemical Sciences, University of Padua investigated and confirmed the effectiveness of inorganic 4D nanoparticles in the biomedical field. 4D nanomedicine offers several advantages to the biomedical field including reduced side effects in a living organism, minimal environmental impact, improved quality of care, and spontaneous effect.

In November 2019, Bristol-Myers Squibb (BMS), a US-based pharmaceutical company completed the acquisition of Celgene for $74 billion. Under this acquisition, Celgene will be a wholly-owned subsidiary of BMS and Bristol-Myers Squibb plans to expand its range of innovative medicines. Celgene is a US-based biopharmaceutical company that focuses on improving the lives of patients through innovative therapies using nanomedicine and nanotechnology.

The rising burden of complex and chronic diseases across the globe is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is increasingly being used in treating chronic diseases including cardiovascular disorders, diabetes, cancer, dementia, and others where it helps in the fast metabolism of drugs in the body. According to the international federation of Alzheimer's associations, Alzheimer's Disease International, more than 50 million people are suffering from dementia globally, and is projected to double every 20 years, which will reach 80 million by 2030 and 152 million by 2050. In 2020, the total cancer burden in the world increased to 19.3 million new cases and is predicted to rise to 28.4 million new cancer cases in 2040. This increasing burden of chronic diseases is expected to propel the demand for effective therapeutics treatment based on nanomedicine, thus driving the market.

The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Pfizer Inc.
  • Nanotherapeutics Inc.
  • NanoViricides Inc
  • Arrowhead Research Inc.
  • Celgene Corporation
  • Bio-Gate AG
  • Merck AG
  • Ablynx NV
  • F. Hoffmann-La Roche AG
  • Nanospectra Biosciences
  • GE Healthcare
  • Gilead Sciences Inc.
  • Novaratis AG
  • Amgen Inc.
  • Sanofi

Methodology

Loading
LOADING...